CareDx
About:
CareDx provides transplant lab products.
Website: https://www.caredx.com/
Twitter/X: CareDx
Top Investors: TPG, Bristol-Myers Squibb, Intel Capital, Kleiner Perkins, Silicon Valley Bank
Description:
CareDx is a molecular diagnostics company. They offer noninvasive surveillance tests to help identify injuries and rule out rejection. They deliver solutions that support a broad spectrum of needs, from initial matching to post-transplant monitoring and care.
Total Funding Amount:
$575M
Estimated Revenue Range:
$100M to $500M
Headquarters Location:
Brisbane, California, United States
Founded Date:
1998-01-01
Contact Email:
customercare(AT)caredx.com
Founders:
Jay Wohlgemuth, Reginald Seeto
Number of Employees:
501-1000
Last Funding Date:
2021-01-21
IPO Status:
Public
© 2025 bioDAO.ai